TRANSCODE THERAPEUTICS, INC. (RNAZ) Free cash flow 2021–2025
TRANSCODE THERAPEUTICS, INC. (RNAZ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$19.5MFY2025 · since FY2021: -$5.5M → -$19.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.5M | -46.2% |
| FY2024 | -$13.4M | +26.2% |
| FY2023 | -$18.1M | -14.2% |
| FY2022 | -$15.9M | -187.3% |
| FY2021 | -$5.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice